Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
MIAMI, FL, June 01, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
MIAMI, FL, June 01, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
List price of $995 per carton for two 40 mg/0.8 mL autoinjectors REDWOOD CITY, Calif.,…
List price of $995 per carton for two 40 mg/0.8 mL autoinjectors REDWOOD CITY, Calif.,…
MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
UTRECHT, The Netherlands and PHILADELPHIA, June 01, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
UTRECHT, The Netherlands and PHILADELPHIA, June 01, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts…
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts…
SAN JOSE, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
SAN JOSE, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
ZUG, Switzerland and BOSTON, June 01, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
ZUG, Switzerland and BOSTON, June 01, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…